Immunic | VTL - Beneficio Bruto En Ventas

Precio De Mercado
1.19
Cambio Diario
0.09 8.18%
Mensual
32.47%
Anual
1.71%
Q1 Expectativa
1.07




Beneficio Bruto En Ventas Cambio Fecha
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Cipla INR 41.64B 6.31B 2025-12
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Grifols EUR 766.49M 39.74M 2024-12
Immunic 0 0 2025-03
Insmed USD 217.69M 106.25M 2025-12
Omeros USD -33.16M 18.52M 2024-06
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Xoma 992K 846K 2024-06